HealthEquity

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

HQY reports strong Q1 performance, faces challenges in seasonality and yield expectations

HQY's Q1 performance reflects strong growth and positive financial results, driven by increased HSA adoption and employer interest. However, the company faces challenges related to seasonality and yield expectations. To capitalize on opportunities, HQY should focus on reaching its enhanced rates target and addressing service fee pressures.

HealthEquity reports robust Q2 performance and eyes market expansion

HealthEquity's strong Q2 performance, driven by revenue and EBITDA growth, is supported by the enhanced rates product and expanded network partner footprint. While facing short-term challenges in interchange revenue and M&A environment changes, the company is well-positioned to capitalize on opportunities presented by market dynamics and regulatory discussions.

HealthEquity reports robust Q3 performance and optimistic fiscal '25 outlook

HealthEquity's Q3 performance showcased strong financial results, with raised fiscal '24 guidance and optimistic initial fiscal '25 guidance. The company is well-positioned to navigate challenges and capitalize on opportunities, particularly in expanding its market presence and enhancing customer satisfaction.

HealthEquity (HQY) posts record earnings, eyes growth through innovation

HealthEquity (HQY) delivered strong financial results, exceeding expectations and demonstrating growth across key metrics.
While facing challenges in certain business segments, the company's focus on technology, customer experience, and long-term quality positions it well for the future.
Opportunities for R&D acceleration, innovation through M&A, and expansion of product offerings present avenues for sustained growth and competitive advantage.

HealthEquity reports robust Q1 results, raises fiscal '24 guidance

HealthEquity's Q1 performance reflects strong financial growth and stability, with revenue, EBITDA, and HSA metrics showing positive trends.
The company's proactive approach to guidance revision, service fee optimization, and strategic partnerships positions it well for future success.
Challenges in managing fee pressures, COBRA impact, and M&A environment slowdown require focused strategies for sustained growth and market leadership.

HealthEquity reports robust Q2 results, eyes growth amid market shifts

HealthEquity's Q2 results reflect strong financial performance and strategic positioning for future growth.
Despite challenges in revenue consistency and market dynamics, the company's strengths in service quality and market leadership are key assets.
Opportunities in revenue growth, legislative changes, and market demand provide avenues for HealthEquity's continued success.

HealthEquity reports strong Q3 growth and bullish outlook for fiscal '25

HealthEquity's Q3 2024 earnings call highlighted impressive financial performance, strategic acquisitions, and optimistic guidance for fiscal '25, underlining the company's growth trajectory and market positioning.
While facing challenges in integrating acquisitions, maintaining competitive pricing, and managing asset maturation, HealthEquity remains focused on growth opportunities through enhanced yield products and consumer empowerment.
The company's emphasis on stability, profitability, and reinvestments, coupled with a proactive approach to engaging investors, sets the stage for continued success and market differentiation in the evolving healthcare landscape.

HealthEquity reports robust Q4 earnings, eyes growth through innovation

HealthEquity delivered strong financial results in Q4 2024, showcasing robust revenue growth and operational performance.
The company's focus on enhancing shareholder value, strategic mergers, and technology investments positions it well for future growth.
Challenges in pricing pressures and technology spend trends require careful navigation, while opportunities in HSA cash rates and digital innovations offer avenues for expansion.
Overall, HealthEquity's performance highlights resilience, strategic foresight, and a commitment to driving long-term value for stakeholders.

HealthEquity reports robust Q1 results, eyes cost savings and growth

HealthEquity's Q1 performance reflects strong growth in revenue, EBITDA, and HSA assets, underlining its market strength and operational efficiency.
The company's focus on cost savings, customer experience enhancement, and new sales growth positions it well for future success and market expansion.
While facing challenges in transitioning processes and managing costs, HealthEquity is leveraging opportunities in technology and market expansion to drive continued growth.

HealthEquity reports robust Q2 growth, unveils innovative healthcare payment options

HealthEquity's Q2 performance reflects strong growth and strategic initiatives to enhance healthcare payment options.
While facing challenges in margins and market conditions, the company's focus on innovation and team efforts bode well for future success.
Opportunities lie in leveraging HPAs, digital integration, and market expansion to drive continued growth and customer value.
Overall, HealthEquity's performance and outlook demonstrate resilience and a commitment to driving healthcare financial solutions.

HealthEquity reports robust Q3 growth amidst challenges and opportunities

HealthEquity's Q3 performance reflects strong growth and market positioning, despite challenges in gross profit margins.
The company's focus on legislative support, technology utilization, and diversified revenue streams positions it well for future expansion.
Opportunities in expanding the TAM, enhancing service delivery, and leveraging commuter offerings indicate a promising outlook for HealthEquity.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why HealthEquity (HQY) is a Strong Growth Stock

Honored nationally and across nine states, HealthEquity's culture of innovation, flexibility, and inclusion set a standard for being a place where people want to work Honored nationally and across nine states, HealthEquity's culture of innovation, flexibility, and inclusion set a standard for being a place where people want to work

HealthEquity Caps 2024 With Widespread Recognition For Its Workplace Excellence

HQY's fiscal third-quarter results benefit from robust HSA growth and improved gross margin. It also raises fiscal 2025 guidance.

HealthEquity Stock Falls Despite Q3 Earnings and Revenue Beat

Shares of HealthEquity (HQY) tumbled Tuesday after the health savings account (HSA) custodian's full-year outlook missed forecasts.

HealthEquity Stock Falls on Disappointing Outlook

HealthEquity, Inc. (NASDAQ:HQY ) Q3 2025 Earnings Conference Call December 9, 2024 4:30 PM ET Company Participants Richard Putnam - IR Jon Kessler - President and CEO James Lucania - EVP and CFO Steve Neeleman - Vice Chair and Founder Scott Cutler - upcoming President and CEO Conference Call Participants Gregory Peters - Raymond James Stan Berenshteyn - Wells Fargo Glen Santangelo - Jefferies Allen Lutz - Bank of America Anne Samuel - JPMorgan George Hill - Deutsche Bank Mark Marcon - Baird David Roman - Goldman Sachs David Larsen - BTIG Steven Valiquette - Mizuho Securities Sean Dodge - RBC Capital Markets Operator Good afternoon, and welcome to the HealthEquity Third Quarter 2025 Earnings Conference Call. Please note this event is being recorded.

HealthEquity, Inc. (HQY) Q3 2025 Earnings Call Transcript

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HealthEquity (HQY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

HealthEquity (HQY) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.60 per share a year ago.

HealthEquity (HQY) Beats Q3 Earnings and Revenue Estimates

Highlights of the third quarter include: Revenue of $300.4 million, an increase of 21% compared to $249.2 million in Q3 FY24. Net income of $5.7 million, compared to $14.7 million in Q3 FY24, with non-GAAP net income of $69.4 million, an increase of 33% compared to $52.2 million in Q3 FY24.

HealthEquity Reports Third Quarter Ended October 31, 2024 Financial Results

Beyond analysts' top -and-bottom-line estimates for HealthEquity (HQY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2024.

Unlocking Q3 Potential of HealthEquity (HQY): Exploring Wall Street Estimates for Key Metrics

SHRM-hosted event will focus on tactics and takeaways to help employers combat rising costs that affect employee satisfaction and benefits utilization SHRM-hosted event will focus on tactics and takeaways to help employers combat rising costs that affect employee satisfaction and benefits utilization

HealthEquity 2025 Benefits Trends Unveiled: Cost Transparency and Containment Take Center Stage for Administrators

HealthEquity (HQY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

HealthEquity, Inc. (HQY) Hit a 52 Week High, Can the Run Continue?

HQY's sustained strength in HSAs raises optimism about the stock.

HealthEquity Gains 54.6% YTD: What's Driving the Stock?

HealthEquity's future growth relies heavily on capital reinvestment due to the asset-light nature of the business. High multiples of capital are necessary to ensure each $1 of retained and reinvested earnings is valued highly by the market. The core asset base has hard-to-replicate business advantages that have grown operating earnings at attractive rates which by all means can continue.

HealthEquity: High Marks For Recent Profit Growth

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

Award recognizes Padia's vision to bring client and member experiences to life through an innovative, immersive experience Award recognizes Padia's vision to bring client and member experiences to life through an innovative, immersive experience

HealthEquity CMO Tia Padia Named "Visionary CMO" at MarCom Awards

HealthEquity (HQY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Strength Seen in HealthEquity (HQY): Can Its 3.5% Jump Turn into More Strength?

Here's Why You Should Add HealthEquity Stock to Your Portfolio Now

DRAPER, Utah, Nov. 12, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced that after leading the company for more than 15 years, Jon Kessler, President and Chief Executive Officer, has decided to retire effective January 6, 2025. Mr. Kessler will remain a director and act a special advisor to the Company through April 30, 2025. To succeed Mr. Kessler, the Company announced the appointment of Scott Cutler, who will join HealthEquity as President and CEO and as a director effective January 6, 2025.

HealthEquity Announces Retirement of CEO Jon Kessler; Scott Cutler Appointed Successor

HealthEquity, Inc. (HQY) Soars to 52-Week High, Time to Cash Out?

HealthEquity (HQY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

HealthEquity (HQY) Moves 9.8% Higher: Will This Strength Last?

DRAPER, Utah, Oct. 30, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced plans to release its third quarter of fiscal 2025 financial results following the close of regular stock market trading hours on Monday, December 9, 2024. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, December 9, 2024, at 4:30 p.m. Eastern Time during which management will review the Company's third quarter results.

HealthEquity Announces Third Quarter Earnings Release Date

HealthEquity (HQY) is well positioned to outperform the market, as it exhibits above-average growth in financials.

3 Reasons Growth Investors Will Love HealthEquity (HQY)

HealthEquity wins for advancements in AI-based claims processing at the prestigious international Globee® Awards; HealthEquity's CTO named Chief Technology Officer of the Year for IT Services HealthEquity wins for advancements in AI-based claims processing at the prestigious international Globee® Awards; HealthEquity's CTO named Chief Technology Officer of the Year for IT Services

HealthEquity receives two top honors at the 19th Annual Golden Globee® Awards for Technology

HealthEquity, Inc. (HQY) Hits Fresh High: Is There Still Room to Run?

Doximity

Elevance Health Inc

The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, DOCS and HQY are set to gain the most.

News for HealthEquity Stock (HQY)